TELL CMS: DON’T CHANGE
PART D
COVERAGE

The Centers for Medicare and Medicaid Services (CMS) recently proposed broad, sweeping changes to the Medicare Part D program, which could reduce coverage, choice, access, and affordability for patients. CMS has proposed removing protections on critical medicines for people who need antidepressants, antipsychotics, or immunosuppressants for transplant rejection. The proposal may significantly limit treatment options for people who need antidepressants or immunosuppressants for transplant rejection, and they have indicated they are likely to do the same for antipsychotics in the future. The proposal may significantly limit treatment options for people with cancer by applying new criteria for their coverage. These medicines cannot necessarily be substituted, and losing the existing protections leaves patients vulnerable. Every member of the Senate Finance committee has written CMS to express concerns about the proposed changes. Make your voice heard today. Tell CMS: Don't change Medicare Part D coverage.

What's at stake?